Anti-galectin 9/Gal-9 antibody [1G3]
- BOND RX™ Validated
- What is this?
4
(2 Reviews)
|
(12 Publications)
Mouse Monoclonal galectin 9/Gal-9 antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 12 publications.
View Alternative Names
Galectin-9, Gal-9, Ecalectin, Tumor antigen HOM-HD-21, LGALS9
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-galectin 9/Gal-9 antibody [1G3] (AB153673)
IHC image of galectin 9/Gal-9 staining in Human normal Tonsil formalin fixed paraffin embedded tissue section*, performed on a Leica Bond™ system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab153673, 5μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre
- WB
Lab
Western blot - Anti-galectin 9/Gal-9 antibody [1G3] (AB153673)
All lanes:
Western blot - Anti-galectin 9/Gal-9 antibody [1G3] (ab153673) at 5 µg/mL
Lane 1:
HeLa transfected with galectin 9 / Gal-9 whole cell lysate at 10 µg
Lane 2:
HeLa (wild type control) whole cell lysate at 10 µg
Secondary
All lanes:
Goat anti-mouse IgG polyclonal antibody (HRP conjugated) at 1/10000 dilution
Predicted band size: 40 kDa
Observed band size: 18 kDa,35 kDa
true
Exposure time: 30s
- WB
CiteAb
Western blot - Anti-galectin 9/Gal-9 antibody [1G3] (AB153673)
galectin 9/Gal-9 western blot using anti-galectin 9/Gal-9 antibody [1G3] ab153673. Publication image and figure legend from Barjon, C., Niki, T., et al., 2012, Infect Agent Cancer, PubMed 22805533.
ab153673 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab153673 please see the product overview.
Western blot detection of galectin-9 isoforms using the 1G3 monoclonal antibody. A low amount of S and M galectin-9 isoforms are present in wild-type HeLa cells. These isoforms are readily detected following transfection with the appropriate expression plasmids. The L-isoform is expressed at a lower abundance than the two other forms. The three endogenous isoforms are detected in the protein extracts from the C15 and C666-1 NPC xenografts. The EBV-positive B-cell line REMB1 expresses a high amount of the M-isoform and a very low amount of L-isoform, however no S-isoform could be detected. In contrast with REMB1 cells, the BL2 cells derived from an EBV-negative B-cell lymphoma have no detectable galectin-9. The faint background bands visible after long exposure do not match with any galectin-9 isoform.
false
Reactivity data
Product details
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
Properties and storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Galectins like galectin-9 play essential roles in regulating diverse immune responses. Galectin-9 acts within the immune system by modulating inflammation and apoptosis. It acts as both a pro-apoptotic factor for T cells and a protein mediator in innate immune functions. Galectin-9 proteins can form complexes with other lectins and cell surface receptors contributing to cellular signaling processes.
Pathways
Galectin-9 is integral to the immune system's functional networks. It participates in the T-cell regulation pathways and the innate immunity pathways. In these pathways it interacts with other proteins like TIM-3 which mediates T-cell apoptosis and contributes to immune tolerance. These interaction networks play important roles in maintaining the body's immune homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in immunology 15:1302761 PubMed38390332
2024
Applications
Unspecified application
Species
Unspecified reactive species
Acta pharmaceutica Sinica. B 13:2585-2600 PubMed37425040
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 133: PubMed36594471
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in genetics 13:981145 PubMed36531216
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in genetics 13:771344 PubMed35646093
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 23:197 PubMed35572493
2022
Applications
Unspecified application
Species
Unspecified reactive species
Modern pathology : an official journal of the Unit 33:1182-1192 PubMed32139873
2020
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 12:10099-10105 PubMed31819504
2019
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of pathology 245:468-477 PubMed29732570
2018
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 92: PubMed29695422
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com